Methylation-Specific Droplet Digital PCR: Testing a Novel Triage Tool for HrHPV-Positive Women in the Cervical Cancer Screening Program of Northern Portugal.
Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Sofia SaltaCancer Biology & Epigenetics Group Research Center of IPO Porto (CI-IPOP) Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0000-0002-6707-1263
José Pedro SequeiraCancer Biology & Epigenetics Group Research Center of IPO Porto (CI-IPOP) Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0000-0002-4687-3347
Bárbara Amorim-FernandesCancer Biology & Epigenetics Group Research Center of IPO Porto (CI-IPOP) Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0009-0001-1229-7118
João LoboDepartment of Pathology Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0000-0001-6829-1391
Inês BaldaqueDepartment of Pathology and Laboratory Medicine Clinical Pathology Service Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0000-0002-5487-2926
Paula MonteiroCancer Biology & Epigenetics Group Research Center of IPO Porto (CI-IPOP) Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0000-0002-3482-2307
Fernando TavaresDepartamento de Estudos e Planeamento Coordenação Nacional dos Programas de Rastreio de Base Populacional (CN-Rast_Pop) Direção Executiva do Serviço Nacional de Saúde Alameda Professor Hernâni Monteiro Portaria B Porto Portugal.
Valérie TalyCentre de recherche des cordeliers INSERM Sorbonne Université Université de Paris Cité Équipe 26 Équipe labellisée ligue nationale contre le cancer Paris France.ORCID https://orcid.org/0000-0002-3116-8602
Rui HenriqueDepartment of Pathology Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0000-0003-3171-4666
Carmen JerónimoCancer Biology & Epigenetics Group Research Center of IPO Porto (CI-IPOP) Portuguese Oncology Institute of Porto (IPO Porto) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) R. Dr. António Bernardino de Almeida Porto Portugal.ORCID https://orcid.org/0000-0003-4186-5345
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
cervical cancer screeningcolposcopy referralDNA methylationHPV‐positive women referraltriage
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Methylation-Specific Droplet Digital PCR: Testing a Novel Triage Tool for HrHPV-Positive Women in the Cervical Cancer Screening Program of Northern Portugal. · full record | OpenQuestion